Compounds with both antioxidant and anti-glycation effects, their preparation processes and applications

By improving the structure of decarboxylated carnosine, the compound 3-amino-N-[2-(2-mercapto-1H-imidazol-5-yl)ethyl]propionamide was prepared, which solved the problems of instability of existing antioxidant ingredients and the need for oral administration for anti-glycation. This resulted in excellent antioxidant and anti-glycation effects in cosmetics, improving skin aging problems.

CN118063388BActive Publication Date: 2026-11-17PROYA COSMETICS CO LTD
View PDF 2 Cites 0 Cited by

Patent Information

Application Number
CN202410157583.2
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2024-02-04
Publication Date
2026-11-17
Estimated Expiration
2044-02-04

AI Technical Summary

Technical Problem

Existing antioxidant ingredients are unstable and difficult to achieve excellent results. Anti-glycation ingredients need to be taken orally to be effective and are highly irritating to the skin, resulting in poor anti-aging product efficacy.

Method used

By improving the structure of decarboxylated carnosine, a compound with both antioxidant and anti-glycation effects was prepared. This involved chemical reaction steps with specific ratios and conditions to form the compound 3-amino-N-[2-(2-mercapto-1H-imidazol-5-yl)ethyl]propionamide, which can be used in cosmetics.

Benefits of technology

The compound exhibits excellent antioxidant and anti-glycation capabilities on the skin, significantly improving problems such as dryness, sagging, and dullness, without irritating the skin and with rapid effects.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118063388B_ABST
    Figure CN118063388B_ABST
Patent Text Reader

Abstract

This invention discloses a compound with both antioxidant and anti-glycation effects, its preparation process, and its application. The preparation process includes the following steps: a) taking histamine dihydrochloride, adding di-tert-butyl dicarbonate and NaOH to histamine dihydrochloride to obtain product A; b) adding product A to a methanol solution to make the concentration of product A 0.25-0.35 mol / L, and then adding K2CO3 to deprotect the nitrogen atom on the imidazole ring to obtain product B; c) reacting product B with phenyl thiochloroformate to obtain product C; d) placing product C in an acidic solution containing HCl to deprotect the nitrogen atom on the alkyl chain to obtain product D; e) reacting product D with alanine N-succinic anhydride to obtain product E; f) deprotecting product E under acidic conditions to obtain the final compound. This invention has the advantages of good antioxidant and anti-glycation effects.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention belongs to the field of cosmetic raw materials, and in particular relates to a compound with both antioxidant and anti-glycation effects, its preparation process, and its application. Background Technology

[0002] The skin is the largest organ in the human body and its first line of defense, protecting various tissues and organs from physical, chemical, and biological attacks and stimuli, preventing moisture loss, and providing structural support. However, it is in direct contact with the external environment and is susceptible to environmental pollution, ultraviolet radiation, and other factors. With age and changes in the social environment, people's skin gradually ages, developing wrinkles and making them appear older and less youthful. Scientific research has found that many factors contribute to aging, including prolonged physical labor, long hours without sleep, and irregular eating habits. Two other important factors are oxidation and glycation.

[0003] On the one hand, the human body constantly generates free radicals due to continuous contact with the external environment, including respiration, pollution, and radiation. A moderate amount of free radicals can contribute to immune functions, and the body also has its own system for neutralizing them. However, with the continuous influence of the external environment, coupled with a decline in neutralization capacity with age, excessive free radicals are produced. These free radicals are highly reactive and particularly prone to damaging human cells and tissues, leading to bodily harm and aging. This manifests on the skin as dullness, dryness, and other skin problems.

[0004] On the other hand, sugars ingested by the body travel through the bloodstream, seeking out and attaching to certain proteins. The most vulnerable proteins are collagen and other elastic proteins, ultimately forming a new type of glycated molecule—"advanced glycation end products (AGEs)." This phenomenon, along with the negative effects of carbonylation and aldehyde formation of biological proteins, is collectively known as glycation stress. Glycation stress is also a contributing factor to aging and chronic diseases caused by postprandial hyperglycemia (glucose spike), smoking, excessive alcohol consumption, oxidation, and ultraviolet radiation. Skin glycation stress is associated with dull, rough skin, age spots, loss of skin elasticity, and signs of aging. AGEs accumulate, damaging collagen, reducing elastic fibers, and causing loss of skin elasticity, leading to sagging skin and wrinkles.

[0005] The above situations occur constantly in our daily lives, thus our skin is constantly subjected to AGEs (Advanced Glycation End Products) and free radical damage, leading to a series of problems. We need to use skincare products containing anti-glycation and antioxidant ingredients to combat free radicals and AGEs, protecting our skin and health.

[0006] Antioxidants help capture and neutralize free radicals, eliminating their damage to the body and improving symptoms such as dryness, sagging, dullness, and wrinkles, thus exerting an anti-aging effect. Current technologies often use multiple antioxidants in combination to enhance the product's free radical scavenging effect. However, the synergistic effect between multiple antioxidants is unstable and difficult to achieve optimal antioxidant results. Increasing the amount and quantity of antioxidants simply to improve the product's antioxidant effect can easily irritate the skin and fail to achieve the desired results.

[0007] Anti-glycation ingredients compete with collagen for free sugars, preventing proteins from cross-linking with sugars. They can also interact with already glycated protein products, releasing already cross-linked collagen, thereby effectively inhibiting advanced glycation end products (AGEs). However, most current anti-glycation products target anti-glycation in the body through oral administration. For the active ingredients to reach the skin and organs and exert their anti-glycation effects, they must pass through the digestive and circulatory systems, resulting in a long onset time and limited functionality.

[0008] Carnosine (β-alanyl-L-histidine) is a dipeptide composed of two amino acids, β-alanyl and L-histidine. Carnosine has the function of scavenging free radicals and has a protective effect against photoaging of the skin. Carnosine also has a certain anti-glycation effect. Before sugar erodes the skin, it can react with sugar in a way that replaces the reaction between proteins and sugar in the body, thereby helping to protect proteins from glycation and achieving the effect of anti-glycation.

[0009] Decarboxycarnosine (HCl), scientifically known as β-alanyl-L-histamine, is a product of carnosine after decarboxylation. As a derivative of carnosine, decarboxycarnosine not only retains carnosine's outstanding antioxidant and anti-glycation capabilities but also enhances its resistance to enzymatic degradation. After structural optimization, decarboxycarnosine is more stable than carnosine under specific physiological conditions, can be added in high concentrations without discoloration, and can protect collagen and elastin from oxidative stress damage. Based on its structure-activity relationship, this invention improves the structure of decarboxycarnosine to obtain superior antioxidant and anti-glycation effects, making it a promising cosmetic anti-aging ingredient. Summary of the Invention

[0010] The purpose of this invention is to provide a compound and its preparation process that possess both antioxidant and anti-glycation effects. This invention has the advantages of good antioxidant and anti-glycation effects.

[0011] The technical solution of this invention: a compound possessing both antioxidant and anti-glycation effects, the structural formula of which is as follows.

[0012]

[0013] The preparation process of the aforementioned compound includes the following steps:

[0014] a) Take histamine dihydrochloride, add di-tert-butyl dicarbonate and NaOH to histamine dihydrochloride to obtain product A.

[0015] b. Add product A to a methanol solution to achieve a concentration of 0.25-0.35 mol / L, then add K₂CO₃ to deprotect the nitrogen atom on the imidazole ring, yielding product B.

[0016] c. Product B reacts with phenyl thiochloroformate to give product C.

[0017] When products d and C are placed in an acidic solution containing HCl, the nitrogen atoms on the alkyl chains are deprotected, yielding product D.

[0018] Product e and product D react with alanine N-succinic acid imide to give product E.

[0019] f and E are deprotected under acidic conditions to obtain the final product of the compound.

[0020] In the aforementioned preparation process of the compound, in step a, the concentration of histamine dihydrochloride is 0.05-0.15 mol / L, the concentration of di-tert-butyl dicarbonate is 0.25-0.35 mol / L, and the concentration of NaOH is 1.5-2.5 mol / L.

[0021] In the aforementioned compound preparation process, in step b, the molar ratio of product A to K2CO3 is 1:(2.5-3.5), and the concentration of product A is 0.25-0.35 mol / L.

[0022] In the aforementioned compound preparation process, in step c, the molar ratio of product B to phenyl thiochloroformate is 1:(2-3).

[0023] In the aforementioned compound preparation process, in step d, the molar ratio of product C to HCl is 1:(15-25), and the concentration of HCl is 0.8-1.2 mol / L.

[0024] In the aforementioned compound preparation process, in step e, the molar ratio of product D to alanine N-succinic acid imide is 1:(1-2).

[0025] In the aforementioned compound preparation process, in step f, the acidic condition is specifically a 0.8-1.2 mol / L HCl solution at 55-65℃, and the molar ratio of product E to HCl is 1:(15-25).

[0026] The aforementioned compound is used in cosmetics.

[0027] In the aforementioned applications of the compound, the concentration of the compound added in cosmetics is 0.016-10 mM.

[0028] Compared with the prior art, the present invention is based on the structure-activity relationship of decarboxylated carnosine and improves its structure. According to experimental results, the compound of the present invention has better antioxidant and anti-glycation effects, and is a promising cosmetic anti-aging functional raw material with huge market application value. Attached Figure Description

[0029] Figure 1 This is the NMR characterization diagram of the compound.

[0030] Figure 2 This is a process synthesis route diagram of the present invention.

[0031] Figure 3 It is a line graph from the experimental example.

[0032] Figure 4 This is a comparison of the immunofluorescence results of carboxymethyl lysine in the experimental example. Detailed Implementation

[0033] The present invention will be further described below with reference to embodiments, but these embodiments are not intended to limit the scope of the invention.

[0034] Example 1. A compound with both antioxidant and anti-glycation effects, named 3-amino-N-[2-(2-mercapto-1H-imidazol-5-yl)ethyl]propionamide, with the following structural formula:

[0035]

[0036] The NMR characterization results of the compound are as follows: Figure 1 As shown.

[0037] Example 2. The preparation process of the compound in Example 1, as follows: Figure 2 As shown, it includes the following steps:

[0038] a. Take histamine dihydrochloride, add di-tert-butyl dicarbonate and NaOH to the histamine dihydrochloride to obtain product A. The molar ratio of histamine dihydrochloride, di-tert-butyl dicarbonate, and NaOH is 1:3:5. The concentration of histamine dihydrochloride is 0.05-0.15 mol / L, the concentration of di-tert-butyl dicarbonate is 0.25-0.35 mol / L, and the concentration of NaOH is 1.5-2.5 mol / L. Under optimal concentrations: histamine dihydrochloride concentration is 0.1 mol / L, di-tert-butyl dicarbonate concentration is 0.3 mol / L, and NaOH concentration is 2 mol / L.

[0039] b. Add product A to a methanol solution. The concentration of product A after adding methanol solution is 0.25-0.35 mol / L, with an optimal concentration of 0.3 mol / L. Then add K2CO3 to deprotect the nitrogen atom on the imidazole ring, yielding product B. The molar ratio of product A to K2CO3 is 1:(2.5-3.5), with an optimal ratio of 1:3.

[0040] c. Product B reacts with phenyl thiochloroformate to yield product C. The molar ratio of product B to phenyl thiochloroformate is 1:(2-3). At the optimal concentration, the molar ratio of product B to phenyl thiochloroformate is 1:2.5.

[0041] Product d and product C are placed in an acidic solution containing 1 mol / L HCl to deprotect the nitrogen atoms on the alkyl chains, yielding product D. The molar ratio of product C to HCl is 1:(15-25), with the optimal molar ratio being 1:20. The concentration of HCl is 0.8-1.2 mol / L, with the optimal concentration being 1 mol / L.

[0042] Product e and product D react with alanine N-succinic acid imide to obtain product E. The molar ratio of product D to alanine N-succinic acid imide is 1:(1-2), and the optimal molar ratio is 1:1.5.

[0043] f and E are deprotected in 0.8-1.2 mol / L HCl solution at 55-65℃ to obtain the final product of the compound. The optimal concentration of HCl solution is 1 mol / L, and the optimal temperature is 60℃.

[0044] Experimental Example. Experimental materials included: analytical balance (Sartorius), multi-functional microplate reader (TECAN), ultrasonic cleaner (Kunshan Shumei), CO2 incubator (Thermo, 150I), clean bench (Sujing Antai, SW-CJ-1F), fluorescence microscope (Leica, DM2500), pipettes (Eppendorf), multi-well plates (Corning), centrifuge tubes (Corning), 1,1-diphenyl-2-trinitrophenylhydrazine, DPPH (TCI), anhydrous ethanol (Maclean), 3D full-thickness skin model culture medium (Guangdong Boxi Biotechnology), PBS (Solepro), paraformaldehyde (Biosharp), methylglyoxal (Sigma), aminoguanidine sulfate (Sigma), and carboxymethyl lysine antibody (Abcam).

[0045] Antioxidant activity tests were performed on the product of Example 1 obtained according to Example 2. The experiment was based on the DPPH assay principle: 1,1-diphenyl-2-trinitrophenylhydrazine (DPPH) radical is a synthetically produced nitrogen-centered radical, characterized by stability, sharp color change, good linearity, and simple and rapid operation. DPPH radical has a single electron and exhibits strong absorption at 517 nm, turning its alcoholic solution purple. When a free radical scavenger is present, its absorption gradually disappears due to electron pairing, and the degree of fading is quantitatively related to the number of electrons it accepts. Therefore, rapid quantitative analysis can be performed using a microplate reader. This experiment is one of the main methods for screening antioxidants.

[0046] Experimental methods for scavenging DPPH free radicals:

[0047] Reagent preparation

[0048] 1) 2x10 -4 Preparation of mol / L DPPH ethanol solution: Weigh 20 mg DPPH, dissolve it in anhydrous ethanol and dilute to 250 ml in a volumetric flask, and store at 4°C protected from light for two weeks.

[0049] 2) Sample preparation (3-amino-N-[2-(2-mercapto-1H-imidazol-5-yl)ethyl]propionamide, labeled P4T3, hereinafter the same): Dissolve and dilute directly with distilled water. Accurately weigh 10 mg of the sample to be tested, dissolve it in 1 mL of distilled water, and dilute it accordingly to obtain the detection concentration. The concentrations set for this experiment are: 10 mM, 2 mM, 0.4 mM, 0.08 mM, 0.16 mM, and 0.0032 mM.

[0050] 3) Preparation of control sample (decarboxylated carnosine): The concentration is exactly the same as that set for the P4T3 sample.

[0051] Experimental steps

[0052] 1) Take an equal volume (750 μL) of sample solution and mix it with DPPH solution, and name it tube A1.

[0053] 2) Take an equal volume of distilled water and DPPH solution, mix them well, and name the tube A2.

[0054] 3) Take an equal volume (750 μL) of sample solution and mix it with anhydrous ethanol, then name it tube A3.

[0055] 4) Perform three replicates for each sample. After reacting in the dark for 30 minutes, measure the absorbance of tubes A1, A2, and A3 at 517 nm using a microplate reader.

[0056] 5) Calculation formula: Clearance rate (%) = [(A2+A3)-A1] / A2.

[0057] 6) The DPPH free radical scavenging ability of samples at different concentrations was determined, and the results are shown in Table 1. The scavenging rate (%) was plotted on the ordinate, and the sample concentration on the x-axis. The data was then processed and plotted as follows: Figure 3 The line graph shown is derived from Table 1 and Figure 3 To determine the antioxidant capacity of a sample.

[0058]

[0059] Table 1

[0060] The higher the DPPH scavenging rate, the better the antioxidant performance. Experimental results show that the DPPH scavenging ability of the compound is far superior to that of decarboxyl carnosine, that is, the antioxidant capacity is far superior to that of decarboxyl carnosine.

[0061] Anti-glycation functional tests were conducted on the product of Example 1 obtained according to Example 2. The experiment was based on the principle of carboxymethyl lysine immunofluorescence assay: Advanced Glycation End Products (AGEs) are a class of harmful substances formed at the end of the Maillard reaction, and carboxymethyl lysine is a typical AGE. Using fluorescently labeled carboxymethyl lysine antibodies, an antigen-antibody immunoreaction was performed on a skin model, and the changes in carboxymethyl lysine content in the skin model under different treatment conditions were detected. This is one of the main methods used in this laboratory to screen anti-glycation substances.

[0062] Methods for detecting the content of advanced glycation end products (carboxymethyl lysine):

[0063] Test Group

[0064]

[0065] Experimental steps

[0066] 1) Model stimulation and drug administration: The skin model was transferred to a culture dish. The NC group, PC group and sample group were given 3D full-thickness skin model culture medium containing 3mM methylglyoxal. At the same time, the PC group and sample group were treated with subsoil drug administration according to the concentration in the "Test Group" above.

[0067] 2) Model Culture: After drug administration, the model was incubated in a CO2 incubator (37℃, 5% CO2). The model was stimulated and drug administered once daily for a total of 7 times. After the last stimulation and administration, the model was cultured for another 24 hours. After culture, the model surface was cleaned with sterile PBS solution to remove any remaining test material, and any residual liquid inside and outside the model was wiped away with sterile cotton swabs.

[0068] 3) After the model culture is completed, perform immunofluorescence testing.

[0069] 4) Immunofluorescence assay: The model used for detection was circumcised and fixed with 4% paraformaldehyde for 24 hours. Immunofluorescence staining was then performed, and images were taken and observed under a microscope. Statistical analysis was conducted, and the results are shown in Table 2. Figure 4 Results. In Table 2, the integrated optical density (IOD) values ​​reflect the content of carboxymethyl lysine. The higher the value, the higher the content of carboxymethyl lysine, indicating a weaker anti-glycation effect.

[0070]

[0071] Table 2

[0072] Table 2 shows that the average IOD value of the NC group was higher than that of the BC group, indicating the success of this glycation experimental model. Meanwhile, the average IOD value of the PC group was lower than that of the NC group, indicating that the positive standard effectively weakened the glycation model. In summary, this demonstrates the effectiveness of the experimental results. These results indicate that the compound P4T3 of this invention has a good anti-glycation effect, and its effect is superior to that of decarboxylcarnosine.

[0073] Figure 4 In this study, stronger fluorescence indicates a higher concentration of advanced glycation end products (AGEs) (carboxymethyl lysine) and weaker anti-glycation activity. Figure 4 The results show that the fluorescence of the P4T3 group is weaker than that of the NC group and the decarboxylated carnosine group, indicating that the compound has a better anti-glycation effect, and its anti-glycation effect is better than that of decarboxylated carnosine.

[0074] Example 3. The compound described in Example 1 was used in cosmetics at a concentration of 0.016-10 mM.

Claims

1. A compound having both antioxidant and anti-glycation efficacy, characterized in that: The structural formula of the compound is as follows: 。 2. The process for the preparation of a compound according to claim 1, characterized in that: Includes the following steps, a、Take histamine dihydrochloride, add di-tert-butyl dicarbonate and NaOH in histamine dihydrochloride, get A product, the structural formula of A product is , b, A product is added into a methanol solution to make the concentration of the A product 0.25-0.35 mol / L, and then K2CO3 is added to deprotect the nitrogen atom on the imidazole ring to obtain a B product, and the structural formula of the B product is , c. B is reacted with phenyl chlorothioformate to obtain C, the structural formula of C is , When products d and C are placed in an acidic solution containing HCl, the nitrogen atoms on the alkyl chains are deprotected, yielding product D. The structural formula of product D is... , e. Product D reacts with alanine N-succinic acid imide to yield product E, the structural formula of which is... , f and E are deprotected under acidic conditions to obtain the final product of the compound.

3. The preparation process of the compound according to claim 2, characterized in that: In step a, the concentration of histamine dihydrochloride is 0.05-0.15 mol / L, the concentration of di-tert-butyl dicarbonate is 0.25-0.35 mol / L, and the concentration of NaOH is 1.5-2.5 mol / L.

4. The preparation process of the compound according to claim 2, characterized in that: In step b, the molar ratio of product A to K2CO3 is 1:(2.5-3.5).

5. The preparation process of the compound according to claim 2, characterized in that: In step c, the molar ratio of product B to phenyl thiochloroformate is 1:(2-3).

6. The preparation process of the compound according to claim 2, characterized in that: In step d, the molar ratio of product C to HCl is 1:(15-25), and the concentration of HCl is 0.8-1.2 mol / L.

7. The preparation process of the compound according to claim 2, characterized in that: In step e, the molar ratio of product D to alanine N-succinic acid imide is 1:(1-2).

8. The preparation process of the compound according to claim 2, characterized in that: In step f, the acidic conditions are specifically a 0.8-1.2 mol / L HCl solution at 55-65℃, and the molar ratio of product E to HCl is 1:(15-25).

9. The application of the compound according to claim 1, characterized in that: The compound is used in cosmetics.

10. The application of the compound according to claim 9, characterized in that: The concentration of the compound added to cosmetics is 0.016-10 mM.

Citation Information

Patent Citations

  • Coupling product obtained from histamine and an amino acid

    US5792784A

  • Substitution of histidine with 2-thiohistidine in bioactive peptides

    WO2022226360A1